147 related articles for article (PubMed ID: 37267155)
21. Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer.
Sun Y; Sun Q; Tian J; He X
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1413-e1423. PubMed ID: 37167097
[TBL] [Abstract][Full Text] [Related]
22. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
23. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
Ryu YJ; Cho JS; Yoon JH; Park MH
World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
[TBL] [Abstract][Full Text] [Related]
24. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy.
Zhang W; Jiao D; Liu B; Sun S
Med Sci Monit; 2016 Apr; 22():1274-9. PubMed ID: 27084873
[TBL] [Abstract][Full Text] [Related]
26. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
[TBL] [Abstract][Full Text] [Related]
27. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
[TBL] [Abstract][Full Text] [Related]
28. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
29. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
30. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.
Ahn D; Lee GJ; Sohn JH
Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and Risk Factors for Multifocality in Pediatric Thyroid Cancer.
Banik GL; Shindo ML; Kraimer KL; Manzione KL; Reddy A; Kazahaya K; Bauer AJ; Rastatter JC; Zafereo ME; Waguespack SG; Chelius DC; Quintanilla-Dieck L
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1100-1106. PubMed ID: 34734994
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
33. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.
Regalbuto C; Malandrino P; Tumminia A; Le Moli R; Vigneri R; Pezzino V
Thyroid; 2011 Apr; 21(4):383-9. PubMed ID: 21309722
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors for nodal recurrence in differentiated thyroid cancers.
Kaur J; Nadarajan A; Janardhan D; George NA; Thomas S; Varghese BT; Krishna J
Cancer Treat Res Commun; 2023; 36():100728. PubMed ID: 37336036
[TBL] [Abstract][Full Text] [Related]
35. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
36. Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer?
Ozdemir K; Harmantepe AT; Gonullu E; Kocer B; Bayhan Z
Updates Surg; 2023 Apr; 75(3):701-706. PubMed ID: 36871277
[TBL] [Abstract][Full Text] [Related]
37. Bilaterality as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma.
Kim H; Kwon H
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001674
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
39. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
40. How many contralateral papillary thyroid carcinomas can be missed?
Lee KJ; Cho YJ; Kim JG; Lee DH
World J Surg; 2013 Apr; 37(4):780-5. PubMed ID: 23324947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]